Director/PDMR Shareholding

RNS Number : 2157C
Primary Health Properties PLC
09 November 2009
 



Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons


All relevant boxes should be completed in block capital letters.


1.

Name of the issuer



2.

State whether the notification relates to (i) a

transaction notified in accordance with DTR 3.1.2 R, 

(ii) a disclosure made in accordance 

LR 9.8.6R(1) or

(iii) a disclosure made in accordance with section 793 of the Companies Act (2006).




PRIMARY HEALTH PROPERTIES PLC


(I) (II) and (III)

3.

Name of person discharging managerial

responsibilities/director



4.

State whether notification relates to a person

connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person





HARRY HYMAN


CONNECTED TO DIRECTOR HARRY HYMAN


5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficial

interest 1



6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares




PURCHASE BY NEXUS GROUP HOLDINGS LIMITED 

NON BENEFICIAL INTEREST OF DIRECTOR.




ORDINARY SHARES OF 50 PENCE EACH

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them



   

State the nature of the transaction






LLOYDS NOMINEES LIMITED 2,697,660


NEXUS GROUP HOLDINGS LIMITED 40,332


SMITH & WILLIAMSON NOMINEES LIMITED 3,385


CONTRACTS FOR DIFFERENCE over 869,565 ORDINARY SHARES WITH COMMERZBANK AG


BERNARD KELLY  128,471

TIM WALKER-ARNOTT  9,082


ACQUISITION OF 430 NEW ORDINARY SHARES BY NEXUS GROUP HOLDINGS LIMITED 

ALL NEW ORDINARY SHARES HELD DIRECTLY BY NEXUS GROUP HOLDINGS LIMITED (BEING A TOTAL OF 2,741,377 ORDINARY SHARES INCLUDING THIS PURCHASE) ARE SUBJECT TO THE DEBENTURE AND FIXED CHARGE BY ITS BANK OVER ALL OF ITS ASSETS.


9.

Number of shares, debentures or financial

instruments relating to shares acquired



10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

N/A





11.

Number of shares, debentures or financial

instruments relating to shares disposed


12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)


N/A


N/A

13.

Price per share or value of transaction



14.

Date and place of transaction




 279.9 PENCE


9 NOVEMBER 2009, LONDON

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)


 


16.

Date issuer informed of transaction






  56,516          BENEFICIAL

  3,748,495   NON-BENEFICIAL

3,805,011   TOTAL  6.20%


9 NOVEMBER 2009



If a person discharging managerial responsibilities has been granted options by the issuer

complete the following boxes


17.

Date of grant



18.

Period during which or date on which exercisable







19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)







21.

Exercise price (if fixed at time of grant) or

indication that price is to be fixed at the time of exercise



22.

Total number of shares or debentures over which options held following notification






23.

Any additional information


24.

Name of contact and telephone number for queries


RACHEL BUTLIN, COMPANY SECRETARY, J O HAMBRO CAPITAL MANAGEMENT LIMITED
0207 747 5680







Name of authorised official of issuer responsible for making notification


FOR AND ON BEHALF OF J O HAMBRO CAPITAL MANAGEMENT LIMITED AS COMPANY SECRETARY OF PRIMARY HEALTH PROPERTIES PLC


………………………………………..


RACHEL BUTLIN, COMPANY SECRETARY


Date of notification  9 NOVEMBER 2009










Notes:    This form is intended for use by an issuer to make a RIS notification required by DR 3.3.


(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBUBDBRXGGGCC
UK 100

Latest directors dealings